Rennova Health inks convertible debt deal via direct placement

• Rennova Health (OTCPK:RNVA -5.1%) enters into an agreement with accredited investors to issue $1.59M aggregate principal amount of convertible debt and warrants to purchase up to 3M shares of common stock for a total of $1.5M.
• The debentures are convertible at $0.086 per share, but will drop to $0.0531 is the debentures are outstanding after the maturity date.
• Closing date of February 2.